RNVA / Rennova Health, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Rennova Health, Inc.
US ˙ OTCPK

Deler fremragende 43,051,322,257 shares
Insideraktier15.055.001 shares
Insider ejerskab0,03 %
Total Insiders34
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

0 ( )
7520 out of 10998

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

0.000% ( )
7307 out of 10864

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Rennova Health, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Jason Adams Chief Financial Officer - [O] 168.392 47
Aella Ltd. 10% Owner - [10%] 0 0
Kamran Ajami Director - [D] 3.334.615 620
Participations Alcatel-Lucent 10% Owner - [10%] 0 0
Alcimede LLC - 250.000 4.961
Gary L Blum Director - [D] 3.333.333 620
Clifford Joseph Baron 2.500
John Beach Director - [D] 3.333.333 620
Gilbert Antoine Bellini 15.498
Paul Billings 55.000
Carole Anne Demachkie VP, General Manager - [O] 2.064 2.064
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Christopher Eric Diamantis 10% Owner - [10%] 95.450.000 9.545
Epizon Ltd. 10% Owner - [10%] 0 0
Benjamin Frank 100.000
Gordon Gavin J. 75.000
Michael Louis Goldberg Director - [D] 26.667 7
Sharon Lynne Hollis 10% Owner - [10%] 24.580 7
Jonathan Immordino 0
Jeffrey M Krauss 67.931
James Karis Director - [D] 3.000 3.000
Seamus Lagan CEO and President, Director - [D] [O] 26.666.765 4.961
Trevor Langley Director - [D] 3.333.333 620
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Robert P Lee Director - [D] 500.254 139
George Lundberg 1.450
Austin W & Greenhouse David M Marxe 10% Owner - [10%] 14.722.529 14.722.529
Thomas Mika Director, CEO and President, Director - [D] [O] 303.839 303.839
Marlene McLennan 0
Thomas Francis DO Mendolia 10% Owner - [10%] 0 0
Samuel R Jr Mitchell Chief Operating Officer - [O] 0 0
Carl Muscari Director - [D] 5.340 5.340
Michael H Pollack 0
Francisco III Roca 10% Owner - [10%] 0 0
Steven Sramowicz 10% Owner - [10%] 3.739.847 1.041
Vidwans Smruti J. 2.200

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i RNVA / Rennova Health, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2016-07-14 Lagan Seamus 9.000 0,2800 3 1.005,4333 2.520 235 2.96 -2.514 -99,77
2016-07-14 Diamantis Christopher Eric 333.333 0,4400 93 1.579,9667 146.667
2016-07-14 Adams Jason 1.160 0,2801 0 1.005,7924 325
2016-07-14 Goldberg Michael Louis 2.500 0,2804 1 1.006,8697 701
2016-06-08 Lagan Seamus 1.900 0,8800 1 3.159,9333 1.672
2016-06-07 Adams Jason 270 0,7450 0 2.675,1708 201
2016-06-03 Adams Jason 295 0,6300 0 2.262,2250 186
2016-05-23 Goldberg Michael Louis 1.500 0,6100 0 2.190,4083 915

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

RNVA / Rennova Health, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i RNVA / Rennova Health, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2012-10-05 Alcatel-Lucent Participations 7.843 4,6000 7.843 4,6000 36.078 730
2012-10-05 Alcatel-Lucent Participations 16.094 4,5900 16.094 4,5900 73.871
2012-10-05 Alcatel-Lucent Participations 1.922 4,5500 1.922 4,5500 8.745
2012-10-05 Alcatel-Lucent Participations 350 4,5200 350 4,5200 1.582
2012-10-05 Alcatel-Lucent Participations 12.800 4,5000 12.800 4,5000 57.600
2012-10-05 Alcatel-Lucent Participations 1.500 4,4600 1.500 4,4600 6.690
2012-10-05 Alcatel-Lucent Participations 18.500 4,4500 18.500 4,4500 82.325
2012-10-05 Alcatel-Lucent Participations 468 4,4200 468 4,4200 2.069
2012-10-05 Alcatel-Lucent Participations 1.832 4,3300 1.832 4,3300 7.933

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

RNVA / Rennova Health, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2021-09-27 2021-08-27 4 Diamantis Christopher Eric RNVA Series M Convertible Redeemable Preferred Stock J - Other D -570 20.180
2021-09-27 2021-08-27 4 Diamantis Christopher Eric RNVA Warrants to Purchase Common Stock J - Other D 0,01 47.500.000 47.500.000
2021-09-27 2021-08-27 4 Diamantis Christopher Eric RNVA Common Stock J - Other D 95.000.000 95.450.000
2018-07-25 2018-07-23 4 Lagan Seamus By: Alcimede LLC RNVA Series J Convertible Preferred Stock A - Award I 0,00 1,0000 250.000 250 250.000
2018-05-14 2018-03-06 4 Beach John RNVA Common Stock A - Award D 3.333.333 3.333.333
2018-03-08 2018-03-06 4 BLUM GARY L RNVA Common Stock A - Award D 3.333.333 3.333.333
2018-03-08 2018-03-06 4 Ajami Kamran RNVA Common Stock A - Award D 3.333.333 3.334.615
2018-03-08 2018-03-06 4 Diamantis Christopher Eric RNVA Common Stock A - Award D 3.333.333 3.337.366
2018-03-08 2018-03-06 4 Langley Trevor RNVA Common Stock A - Award D 3.333.333 3.333.333
2018-03-08 2018-03-06 4 Lagan Seamus RNVA Common Stock A - Award D 26.666.667 26.666.765
2017-08-17 2017-08-15 4 Diamantis Christopher Eric RNVA Restricted Stock A - Award D 100.000 100.000
2017-08-17 2017-08-15 4 Lagan Seamus RNVA Restricted Stock A - Award D 200.000 200.000
2017-08-17 2017-08-15 4 Ajami Kamran RNVA Restricted Stock A - Award D 100.000 100.000
2017-08-17 2017-08-15 4 Langley Trevor RNVA Restricted Stock A - Award D 100.000 100.000
2017-05-02 3 Ajami Kamran RNVA Common Stock D 38.480
2017-05-02 3 Ajami Kamran RNVA Common Stock D 38.480
2017-04-18 2017-03-21 4 Diamantis Christopher Eric RNVA Warrants to Purchase Common Stock J - Other D 1,66 250.000 250.000
2017-02-16 2016-11-15 4 Sramowicz Steven RNVA Warrants to Purchase Common Stock J - Other D 0,45 222.222 222.222
2017-02-16 2016-11-15 4 Sramowicz Steven RNVA Common Stock J - Other D 0,4500 222.222 100 3.739.847
2017-02-15 2016-09-21 4 Sramowicz Steven RNVA Series B Convertible Preferred Stock C - Conversion D -1.000 0
2017-02-15 2016-09-21 4 Sramowicz Steven RNVA Common Stock C - Conversion D 1.146.789 3.517.625
2017-02-15 2016-08-05 4 Sramowicz Steven RNVA Warrants to Purchase Common Stock J - Other D 0,45 515.177 515.177
2017-02-15 2016-08-05 4 Sramowicz Steven RNVA Common Stock J - Other D 0,4500 515.177 232 2.370.836
2016-11-30 2016-09-21 4 Roca Francisco III RNVA Series B Convertible Preferred Stock C - Conversion D -1.000 0
2016-11-30 2016-09-21 4 Roca Francisco III RNVA Common Stock C - Conversion D 1.146.789 3.739.847
2016-09-22 2016-09-21 4 Aella Ltd. RNVA Series B Convertible Preferred Stock C - Conversion D -1.000 0
2016-09-22 2016-09-21 4 Aella Ltd. RNVA Common Stock C - Conversion D 1.146.789 3.073.493
2016-09-22 2016-09-21 4 Epizon Ltd. RNVA Series B Convertible Preferred Stock C - Conversion D -1.000 0
2016-09-22 2016-09-21 4 Epizon Ltd. RNVA Common Stock C - Conversion D 1.146.789 3.887.222
2016-09-22 2016-09-21 4 Mendolia Thomas Francis DO RNVA Series B Convertible Preferred Stock C - Conversion D -1.000 0
2016-09-22 2016-09-21 4 Mendolia Thomas Francis DO RNVA Common Stock C - Conversion D 1.146.789 3.739.847
2016-09-14 2016-08-05 4 Lagan Seamus By: Alcimede LLC RNVA Common Stock J - Other I 0,3000 1.171.667 352 1.926.928
2016-09-14 2016-07-25 4 Lagan Seamus By: Alcimede LLC RNVA Common Stock J - Other I 0,3000 333.334 100 755.261
2016-09-14 2016-07-17 4 Lagan Seamus RNVA Options to Purchase Common Stock A - Award D 0,30 500.000 500.000
2016-09-14 2016-07-17 4 Lagan Seamus RNVA Options to Purchase Common Stock A - Award D 0,30 500.000 500.000
2016-09-14 2016-07-17 4 Lagan Seamus RNVA Options to Purchase Common Stock A - Award D 0,30 250.000 250.000
2016-09-14 2016-07-17 4 Lagan Seamus RNVA Options to Purchase Common Stock A - Award D 0,30 250.000 250.000
2016-09-14 2016-07-17 4 Lagan Seamus RNVA Options to Purchase Common Stock A - Award D 0,30 250.000 250.000
2016-09-14 2016-07-17 4 Lagan Seamus RNVA Options to Purchase Common Stock A - Award D 0,30 250.000 250.000
2016-09-14 2016-07-17 4 Lagan Seamus RNVA Common Stock A - Award D 0,3000 333.334 100 344.234
2016-09-13 2016-08-05 4 Roca Francisco III RNVA Warrants to Purchase Common Stock J - Other D 0,45 737.399 737.399
2016-09-13 2016-08-05 4 Roca Francisco III RNVA Common Stock J - Other D 0,4500 737.399 332 2.593.058
2016-09-13 2016-07-17 4 Mendolia Thomas Francis DO RNVA Options to Purchase Common Stock A - Award D 0,30 20.000 20.000
2016-08-30 2016-08-05 4 Epizon Ltd. RNVA Common Stock J - Other D 0,3000 856.099 257 2.740.433
2016-08-29 2016-08-05 4 Diamantis Christopher Eric RNVA Warrants to Purchase Common Stock J - Other D 0,45 1.133.338 1.133.338
2016-08-29 2016-08-05 4 Diamantis Christopher Eric RNVA Common Stock J - Other D 0,4500 1.133.338 510 1.814.864
2016-08-29 2016-07-17 4 Diamantis Christopher Eric RNVA Options to Purchase Common Stock A - Award D 0,30 120.000 120.000
2016-08-25 2016-08-05 4 Mendolia Thomas Francis DO RNVA Warrants to Purchase Common Stock J - Other D 0,45 737.399 737.399
2016-08-25 2016-08-05 4 Mendolia Thomas Francis DO RNVA Common Stock J - Other D 0,4500 737.399 332 2.593.058
2016-08-23 2016-08-05 4 Aella Ltd. RNVA Common Stock J - Other D 0,3000 83.334 25 1.926.704
2016-08-22 2016-07-17 4 Frank Benjamin RNVA Options to Purchase Common Stock A - Award D 0,30 100.000 100.000
2016-08-22 2016-08-05 4 Lee Robert P RNVA Common Stock J - Other D 0,3000 250.027 75 500.254
2016-08-22 2016-07-17 4 Lee Robert P RNVA Options to Purchase Common Stock A - Award D 0,30 120.000 120.000
2016-08-18 2016-08-05 4 Goldberg Michael Louis By: Monarch Capital LLC RNVA Common Stock J - Other I 0,3000 26.667 8 26.667
2016-08-18 2016-07-17 4 Goldberg Michael Louis RNVA Options to Purchase Common Stock A - Award D 0,30 300.000 300.000
2016-08-05 2016-05-02 4/A Lagan Seamus RNVA Options to Purchase Common Stock A - Award D 1,00 250.000 250.000
2016-08-05 2016-05-02 4/A Lagan Seamus RNVA Options to Purchase Common Stock A - Award D 10,00 1.000.000 1.000.000
2016-08-05 2016-05-02 4/A Lagan Seamus RNVA Options to Purchase Common Stock A - Award D 5,00 1.000.000 1.000.000
2016-07-27 2016-07-17 4 Adams Jason RNVA Options to Purchase Common Stock A - Award D 0,30 300.000 300.000
2016-07-27 2016-07-17 4 Adams Jason RNVA Common Stock A - Award D 166.667 168.392
2016-07-19 2016-07-14 4 Goldberg Michael Louis RNVA Common Stock P - Purchase D 0,2804 2.500 1 7.110
2016-07-19 2016-07-14 4 Diamantis Christopher Eric RNVA Warrants (right to buy) P - Purchase D 0,45 0,0100 333.333 3 333.333
2016-07-19 2016-07-14 4 Diamantis Christopher Eric RNVA Common Stock P - Purchase D 0,4400 333.333 147 681.526
2016-07-15 2016-07-14 4 Lagan Seamus RNVA Common Stock P - Purchase D 0,2800 9.000 3 10.900
2016-07-15 2016-06-08 4 Lagan Seamus RNVA Common Stock P - Purchase D 0,8800 1.900 2 1.900
2016-07-15 2016-07-14 4 Adams Jason RNVA Common Stock P - Purchase D 0,2801 1.160 0 1.725
2016-06-09 2016-06-07 4 Adams Jason RNVA Common Stock P - Purchase D 0,7450 270 0 565
2016-06-06 2016-06-03 4 Adams Jason RNVA Common Stock P - Purchase D 0,6300 295 0 295
2016-05-27 2016-05-02 4 Sramowicz Steven RNVA Options to Purchase Common Stock A - Award D 10,00 1.000.000 1.000.000
2016-05-27 2016-05-02 4 Sramowicz Steven RNVA Options to Purchase Common Stock A - Award D 5,00 1.000.000 1.000.000
2016-05-24 2016-05-23 4 Goldberg Michael Louis RNVA Common Stock P - Purchase D 0,6100 1.500 1 1.500
2016-05-20 2016-05-02 4 Lagan Seamus RNVA Options to Purchase Common Stock A - Award D 5,00 1.000.000 1.000.000
2016-05-20 2016-05-02 4 Lagan Seamus RNVA Options to Purchase Common Stock A - Award D 10,00 1.000.000 1.000.000
2016-05-18 2016-05-02 4 Roca Francisco III RNVA Options to Purchase Common Stock A - Award D 5,00 1.000.000 1.000.000
2016-05-18 2016-05-02 4 Roca Francisco III RNVA Options to Purchase Common Stock A - Award D 10,00 1.000.000 1.000.000
2016-05-11 2016-05-02 4 Lee Robert P RNVA Options to Purchase Common Stock A - Award D 1,00 120.000 120.000
2016-05-11 2016-05-02 4 Goldberg Michael Louis RNVA Options to Purchase Common Stock A - Award D 1,00 300.000 300.000
2016-05-11 2016-05-02 4 Frank Benjamin RNVA Options to Purchase Common Stock A - Award D 1,00 100.000 100.000
2016-05-11 2016-05-02 4 Diamantis Christopher Eric RNVA Options to Purchase Common Stock A - Award D 1,00 120.000 120.000
2016-05-10 3 Sramowicz Steven RNVA Series B Convertible Preferred Stock D 1.857.659
2016-05-10 3 Sramowicz Steven RNVA Common Stock D 3.712.318
2016-05-10 3 Sramowicz Steven RNVA Series B Convertible Preferred Stock D 1.857.659
2016-05-10 3 Sramowicz Steven RNVA Common Stock D 3.712.318
2016-05-05 3 Hollis Sharon Lynne RNVA Common Stock D 24.580
2016-05-05 3 Hollis Sharon Lynne RNVA Common Stock D 24.580
2016-05-05 2016-05-02 4 Adams Jason RNVA Options to Purchase Common Stock A - Award D 1,00 300.000 300.000
2016-05-05 2016-05-02 4 Mendolia Thomas Francis DO RNVA Options to Purchase Common Stock A - Award D 5,00 1.000.000 1.000.000
2016-05-05 2016-05-02 4 Mendolia Thomas Francis DO RNVA Options to Purchase Common Stock A - Award D 10,00 1.000.000 1.000.000
2016-05-05 2016-05-02 4 Mendolia Thomas Francis DO RNVA Options to Purchase Common Stock A - Award D 1,00 20.000 20.000
2016-01-26 3 The Olive Tree Trust RNVA Series B Convertible Preferred Stock D 1.845.370
2016-01-26 3 The Olive Tree Trust RNVA Series B Convertible Preferred Stock D 1.845.370
2016-01-26 3 The Olive Tree Trust RNVA Common Stock D 3.687.740
2016-01-26 3 The Olive Tree Trust RNVA Series B Convertible Preferred Stock D 1.845.370
2016-01-26 3 The Olive Tree Trust RNVA Common Stock D 3.687.740
2016-01-26 3 The Olive Tree Trust RNVA Common Stock D 3.687.740
2016-01-11 3 The Shanoven Trust RNVA Series B Convertible Preferred Stock D 1.886.334
2016-01-11 3 The Shanoven Trust RNVA Common Stock D 3.769.668
2016-01-11 3 The Shanoven Trust RNVA Series B Convertible Preferred Stock D 1.886.334
2016-01-11 3 The Shanoven Trust RNVA Series B Convertible Preferred Stock D 1.886.334
2016-01-11 3 The Shanoven Trust RNVA Common Stock D 3.769.668
2016-01-11 3 The Shanoven Trust RNVA Common Stock D 3.769.668
2015-12-11 3 Diamantis Christopher Eric RNVA Common Stock D 696.386
2015-12-11 3 Diamantis Christopher Eric RNVA Common Stock D 696.386
2015-11-30 2015-11-02 4 Vidwans Smruti J. RNVA Options to Purchase Common Stock A - Award D 4,80 120.000 120.000
2015-11-30 2014-12-08 4 Vidwans Smruti J. RNVA Options to Purchase Common Stock J - Other D 7,50 1.000 1.000
2015-11-30 2014-07-03 4 Vidwans Smruti J. RNVA Options to Purchase Common Stock J - Other D 19,90 1.200 1.200
2015-11-30 2012-07-12 4 Vidwans Smruti J. RNVA Options to Purchase Common Stock J - Other D 39,40 3.000 3.000
2015-11-30 2015-11-02 4 Baron Clifford Joseph RNVA Options to Purchase Common Stock A - Award D 4,80 145.000 145.000
2015-11-30 2014-12-08 4 Baron Clifford Joseph RNVA Options to Purchase Common Stock J - Other D 7,50 1.000 1.000
2015-11-30 2014-07-03 4 Baron Clifford Joseph RNVA Options to Purchase Common Stock J - Other D 19,90 1.500 1.500
2015-11-30 2014-03-05 4 Baron Clifford Joseph RNVA Options to Purchase Common Stock J - Other D 32,20 4.000 4.000
2015-11-30 2015-11-02 4 Lundberg George RNVA Options to Purchase Common Stock A - Award D 4,80 60.000 60.000
2015-11-30 2014-12-08 4 Lundberg George RNVA Options to Purchase Common Stock J - Other D 7,50 500 500
2015-11-30 2014-07-03 4 Lundberg George RNVA Options to Purchase Common Stock J - Other D 19,90 450 450
2015-11-30 2012-07-12 4 Lundberg George RNVA Options to Purchase Common Stock J - Other D 39,40 1.500 1.500
2015-11-16 3 Alcimede LLC By: Alcimede LLC RNVA Common Stock I 843.854
2015-11-16 3 Alcimede LLC By: Alcimede LLC RNVA Common Stock I 843.854
2015-11-16 3 Alcimede LLC By: Alcimede LLC RNVA Common Stock I 843.854
2015-11-12 3 Lee Robert P RNVA Common Stock D 491.566
2015-11-12 3 Lee Robert P RNVA Common Stock D 491.566
2015-11-12 3 Mitchell Samuel R Jr RNVA Common Stock D 0
2015-11-12 3 Roca Francisco III RNVA Series B Convertible Preferred Stock D 1.857.659
2015-11-12 3 Roca Francisco III RNVA Series B Convertible Preferred Stock D 1.857.659
2015-11-12 3 Roca Francisco III RNVA Common Stock D 3.712.318
2015-11-12 3 Roca Francisco III RNVA Common Stock D 3.712.318
2015-11-12 3 Mendolia Thomas Francis DO RNVA Common Stock D 3.712.318
2015-11-12 3 Mendolia Thomas Francis DO RNVA Common Stock D 3.712.318
2015-11-12 3 Mendolia Thomas Francis DO RNVA Series B Convertible Preferred Stock D 1.857.659
2015-11-12 3 Mendolia Thomas Francis DO RNVA Series B Convertible Preferred Stock D 1.857.659
2015-11-12 3 Adams Jason RNVA Common Stock D 0
2015-11-12 3 Goldberg Michael Louis RNVA Common Stock D 0
2015-01-07 2015-01-01 4 MIKA THOMAS CLRX RESTRICTED STOCK UNIT P - Purchase D 50.000 359.692
2014-12-12 2014-12-08 4 Karis James CLRX Non-Qualified Stock Option P - Purchase D 0,75 0,7500 16.179 12 52.500
2014-12-12 2014-12-08 4 KRAUSS JEFFREY M CLRX Non-Qualified Stock Option P - Purchase D 0,75 0,7500 41.300 31 67.931
2014-12-12 2014-12-08 4 GORDON GAVIN J. CLRX Non-Qualified Stock Option P - Purchase D 0,75 0,7500 10.000 8 75.000
2014-12-12 2014-12-08 4 Lundberg George CLRX Non-Qualified Stock Option P - Purchase D 0,75 0,7500 5.000 4 24.500
2014-12-12 2014-12-08 4 Muscari Carl CLRX Non-Qualified Stock Option P - Purchase D 0,75 0,7500 44.200 33 63.398
2014-12-12 2014-12-08 4 Billings Paul CLRX Non-Qualified Stock Option P - Purchase D 0,75 0,7500 32.500 24 55.000
2014-12-12 2014-12-08 4 Baron Clifford Joseph CLRX Common Stock : Non-Qualified Stock Option P - Purchase D 0,75 0,7500 10.000 8 70.833
2014-09-30 2014-09-25 4 Billings Paul CLRX Non-Qualified Stock Option P - Purchase D 1,05 1,0500 2.500 3 22.500
2014-09-30 2014-09-25 4 Karis James CLRX Non Qualified Stock Option P - Purchase D 1,05 1,0500 2.500 3 39.321
2014-09-30 2014-09-25 4 Muscari Carl CLRX Non-Qualified Stock Option P - Purchase D 1,05 1,0500 -2.500 -3 24.538
2014-09-30 2014-09-25 4 KRAUSS JEFFREY M CLRX Non-Qualified Stock Option P - Purchase D 1,05 1,0500 2.500 3 31.547
2014-08-15 2014-08-12 4 Billings Paul CLRX Non-Qualified Stock Option P - Purchase D 1,50 1,5000 10.000 15 20.000
2014-07-10 2014-07-03 4 Baron Clifford Joseph CLRX Non-Qualified Stock Option P - Purchase D 1,99 1,9900 15.000 30 65.000
2014-07-10 2014-07-03 4 Lundberg George CLRX Non-Qualified Stock Option P - Purchase D 1,99 1,9900 4.500 9 19.500
2014-07-10 2014-07-03 4 MIKA THOMAS CLRX Restricted Stock Unit P - Purchase D 100.000 297.528
2014-07-10 2014-07-03 4 Bellini Gilbert Antoine CLRX Non-Qualified Stock Option P - Purchase D 1,99 1,9900 3.000 6 15.498
2014-07-10 2014-07-03 4 KRAUSS JEFFREY M CLRX Non-Qualified Stock Option P - Purchase D 1,99 1,9900 6.200 12 26.706
2014-07-10 2014-07-03 4 Muscari Carl CLRX Non-Qualified Stock Option P - Purchase D 1,99 1,9900 3.300 7 16.698
2014-07-10 2014-07-03 4 Karis James CLRX Non Qualified Stock Option P - Purchase D 1,99 1,9900 7.400 15 33.821
2014-07-10 2014-07-03 4 Billings Paul CLRX Non-Qualified Stock Option P - Purchase D 1,99 1,9900 5.000 10 10.000
2014-07-10 2014-07-03 4 GORDON GAVIN J. CLRX Non-Qualified Stock Option P - Purchase D 1,99 1,9900 15.000 30 65.000
2014-07-03 2014-04-07 4 Karis James CLRX Non Qualified Stock Option P - Purchase D 3,22 3,2200 1.667 5 26.421
2014-07-03 2014-06-23 4 Karis James CLRX Common Stock, 0.01 par value P - Purchase D 1,9600 3.000 6 3.000
2014-07-03 2014-06-23 4 Muscari Carl CLRX Common Stock, par value $0.01 per share P - Purchase D 1,9500 2.500 5 5.340
2014-07-03 2014-04-07 4 KRAUSS JEFFREY M CLRX Non-Qualified Stock Option P - Purchase D 3,22 3,2200 1.667 5 20.506
2014-07-03 2014-04-07 4 Muscari Carl CLRX Non-Qualified Stock Option P - Purchase D 3,22 3,2200 -1.667 -5 13.398
2014-07-03 2014-04-07 4 Bellini Gilbert Antoine CLRX Non-Qualified Stock Option P - Purchase D 3,22 3,2200 1.667 5 12.498
2014-01-29 2014-01-27 4 MIKA THOMAS CLRX Restricted Stock Units M - Exercise D -30.417 303.839
2014-01-29 2014-01-27 4 MIKA THOMAS CLRX Common Stock M - Exercise D 30.417 303.839
2013-12-10 2013-09-26 4 Karis James CLRX Non Qualified Stock Option A - Award D 4,16 4,1600 833 3 24.754
2013-11-20 2013-11-15 4 Muscari Carl CLRX Common Stock, par value $0.01 per share P - Purchase D 3,8500 1.300 5 14.571
2013-11-19 2013-09-26 4 Bellini Gilbert Antoine CLRX Non-Qualified Stock Option P - Purchase D 4,16 4,1600 833 3 10.831
2013-11-19 2013-09-26 4 Muscari Carl CLRX Non-Qualified Stock Option P - Purchase D 4,16 4,1600 -833 -3 13.271
2013-11-19 2013-09-26 4 KRAUSS JEFFREY M CLRX Non-Qualified Stock Option P - Purchase D 4,16 4,1600 833 3 17.931
2013-03-29 2013-03-26 4 Muscari Carl CLRX Common Stock, par value $0.01 per share P - Purchase D 3,2500 1.540 5 12.438
2013-03-28 2012-09-25 4 KRAUSS JEFFREY M CLRX Non-Qualified Stock Option P - Purchase D 3,45 3,4500 833 3 17.098
2013-03-28 2012-09-25 4 Bellini Gilbert Antoine CLRX Non-Qualified Stock Option P - Purchase D 3,45 3,4500 833 3 9.998
2013-03-28 2012-09-25 4 Muscari Carl CLRX Non-Qualified Stock Option P - Purchase D 3,45 3,4500 833 3 10.898
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,4000 -5.000 -22 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,3700 -2.400 -10 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,3600 -200 -1 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,3500 -1.000 -4 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,3300 -1.832 -8 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,3200 -2.000 -9 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,3000 -1.600 -7 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,2900 -800 -3 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,2700 -1.100 -5 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,2600 -8.288 -35 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,2500 -24.768 -105 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,2300 -5.431 -23 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,2200 -20.012 -84 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,2100 -8.362 -35 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,2000 -26.982 -113 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,1800 -3.000 -13 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,1700 -5.600 -23 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,1500 -426 -2 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,1300 -314 -1 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,1200 -250 -1 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,1100 -1.485 -6 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,1000 -4.920 -20 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,0900 -1.700 -7 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,0800 -100 -0 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,0600 -3.100 -13 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,0500 -1.700 -7 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,0400 -1.000 -4 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,0300 -15.000 -60 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,0200 -200 -1 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,0100 -630 -3 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,6000 -7.843 -36 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,5900 -16.094 -74 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,5500 -1.922 -9 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,5200 -350 -2 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,5000 -12.800 -58 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,4600 -1.500 -7 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,4500 -18.500 -82 0
2012-10-09 2012-10-05 4 Alcatel-Lucent Participations CLRX Common Stock, par value $0.01 per share S - Sale D 4,4200 -468 -2 0
2012-08-02 2012-08-01 4 Bellini Gilbert Antoine tgal Non-Qualified Stock Option P - Purchase D 3,47 3,4700 5.000 17 9.165
2012-08-02 2012-08-01 4 KRAUSS JEFFREY M tgal Non-Qualified Stock Options P - Purchase D 3,47 3,4700 5.000 17 16.265
2012-08-02 2012-08-01 4 Muscari Carl tgal Non-Qualified Stock Option P - Purchase D 3,47 3,4700 5.000 17 10.065
2012-07-12 3 Alcatel-Lucent Participations TGAL Common Stock, par value $0.01 D 208.877
2012-07-12 2012-07-10 4 Alcatel-Lucent Participations TGAL Common Stock, par value $0.01 per share S - Sale D 4,0500 -200 -1 208.677
2012-07-12 2012-07-12 4 Karis James TGAL Common Stock A - Award D 239.417 239.417
2012-05-04 2012-03-27 4 Bellini Gilbert Antoine TGAL Non-Qualified Stock Option P - Purchase D 3,43 3,4300 833 3 4.165
2012-05-04 2012-03-27 4 KRAUSS JEFFREY M TGAL Non-Qualified Stock Option P - Purchase D 3,43 3,4300 833 3 11.265
2012-05-04 2012-03-27 4 Muscari Carl TGAL Non-Qualified Stock Option P - Purchase D 3,43 3,4300 833 3 5.065
2012-05-04 2012-04-01 4 MIKA THOMAS TGAL Restricted Stock Unit P - Purchase D 3,47 3,4700 39.000 135 303.839
2006-01-05 2005-12-31 4 MARXE AUSTIN W & GREENHOUSE DAVID M By Limited Partnership TGAL Warrant J - Other I 1,00 0 1.243.239
2006-01-05 2005-12-31 4 MARXE AUSTIN W & GREENHOUSE DAVID M By Limited Partnership TGAL Warrant J - Other I 1,00 0 14.566
2006-01-05 2005-12-31 4 MARXE AUSTIN W & GREENHOUSE DAVID M By Limited Partnership TGAL Warrant J - Other I 1,00 3.089.299 6.021.515
2006-01-05 2005-12-31 4 MARXE AUSTIN W & GREENHOUSE DAVID M By Limited Partnership TGAL Warrant J - Other I 1,00 687.351 1.339.751
2006-01-05 2005-12-31 4 MARXE AUSTIN W & GREENHOUSE DAVID M By Limited Partnership TGAL Common Stock J - Other I 7.553.299 14.722.529
2003-10-07 3 DEMACHKIE CAROLE ANNE TGAL Common Stock D 2.064
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista